Legacy Life Sciences
3
10M
2
0.33
- Stages of investment
- Areas of investment
Summary
Among the various public portfolio startups of the fund, we may underline Sonoma Orthopedics Among the most popular fund investment industries, there are Biotechnology, Medical Device. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The important activity for fund was in 2011. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
The usual cause for the fund is to invest in rounds with 8 partakers. Despite the Legacy Life Sciences, startups are often financed by Asset Management Company, The Halo Fund, The Angels' Forum. The meaningful sponsors for the fund in investment in the same round are Split Rock Partners, MedVenture Associates, InCube Ventures. In the next rounds fund is usually obtained by The Angels' Forum, First Analysis.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Follow on index
- 0.33
- Investments by industry
- Health Care (3)
- Therapeutics (2)
- Medical (2)
- Biotechnology (1)
- Medical Device (1) Show 1 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2011
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| EMKinetics | 18 Oct 2011 | Health Care, Medical, Therapeutics | Late Stage Venture | 8M | United States, California, San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.